Vivek Ramaswamy
Founder at Strive Asset Management LLC
Net worth: 563 M $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Gline | M | 40 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
| Keith Manchester | M | 55 |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA.
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 10 years |
| Frank Torti | M | 45 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
| Anson Frericks | M | - |
Strive Asset Management LLC
 Strive Asset Management LLC Investment ManagersFinance Part of Strive Enterprises, Inc., Strive Asset Management LLC is an asset management firm based in Dublin, OH. The company's mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics. Strive will compete directly with the world's largest asset managers by launching index funds that advance excellence capitalism across corporate America. The private company was founded by Vivek Ramaswamy and Anson Frericks in 2022, and Matthew Cole has been the CEO of the company since 2022. | 2 years |
| Matt Cole | M | - |
Strive Asset Management LLC
Strive Asset Management LLC Investment ManagersFinance Part of Strive Enterprises, Inc., Strive Asset Management LLC is an asset management firm based in Dublin, OH. The company's mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics. Strive will compete directly with the world's largest asset managers by launching index funds that advance excellence capitalism across corporate America. The private company was founded by Vivek Ramaswamy and Anson Frericks in 2022, and Matthew Cole has been the CEO of the company since 2022. | 2 years |
| Eric Venker | M | 37 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 7 years |
| Mayukh Sukhatme | M | 48 | 9 years | |
| Karen Sims | M | 53 | 7 years | |
| Dan Gold | M | 56 | 4 years | |
| Melissa Epperly | F | 46 | 2 years | |
| Jim Momtazee | M | - | 3 years | |
| Rakhi Kumar | F | 44 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 9 years |
| Daniel Burgess | M | 62 | 7 years | |
| James Meyers | M | 59 | 6 years | |
| David Hastings | M | 62 | 6 years | |
| Richard Pulik | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
| Jo Chen | M | - | 4 years | |
| Amy Mahery | F | 47 | 2 years | |
| Kelly Graff | F | - | 4 years | |
| Zachary Carpenter | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| Paul Davis | M | - | 8 years | |
| Andrew Fromkin | M | 58 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
| Srini Ramanathan | M | - | 2 years | |
| Nikhil Kehtarpal | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| Gillian Cannon | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 years |
| Navneet Alag | M | - | 2 years | |
| Paul Davis | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
| Wan Li Zhu | M | - | 3 years | |
| P. Schaefer Price | M | 61 |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | 10 years |
| Jeffrey Sherman | M | - |
Strive Asset Management LLC
Strive Asset Management LLC Investment ManagersFinance Part of Strive Enterprises, Inc., Strive Asset Management LLC is an asset management firm based in Dublin, OH. The company's mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics. Strive will compete directly with the world's largest asset managers by launching index funds that advance excellence capitalism across corporate America. The private company was founded by Vivek Ramaswamy and Anson Frericks in 2022, and Matthew Cole has been the CEO of the company since 2022. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Myrtle Potter | F | 65 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| Frank Karbe | M | 55 | 11 years | |
| David Hung | M | 66 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 years |
| Alan Roemer | M | 54 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
| William T. Symonds | M | 56 |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA.
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 years |
| Pavan Cheruvu | M | 42 | 4 years | |
| Gregory Mark Weinhoff | M | 53 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 4 years |
| Koert VandenEnden | M | 45 | 3 years | |
| Mark Altmeyer | M | 63 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 2 years |
| Elizabeth Howard | M | 70 | 7 years | |
| Michael Jeffrey Abrams | M | 68 | 8 years | |
| Matthew Lang | M | 48 | - | |
| Clarence Machado | M | 60 | 6 years | |
| Shankar Ramaswamy | M | - | 4 years | |
| Marion McCourt | F | 64 | 1 years | |
| Marianne Romeo | F | 56 | - | |
| Kathleen Sebelius | F | 75 | 5 years | |
| Ilise Lombardo | M | - | 4 years | |
| David Johnson | M | 41 |
Harvard College
| 4 years |
| Erik Zwicker | M | 44 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Terrie Curran | F | 55 | 7 years | |
| Samina Bari | M | - | - | |
| Hiroshi Nomura | M | 66 | 4 years | |
| Christine Cvijic | F | 46 | 2 years | |
| Ilan Oren | M | 40 | 5 years | |
| Tony Vernon | M | 68 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 1 years |
| Mark Guinan | M | 62 | 5 years | |
| Peter Lutwyche | M | 58 | 10 years | |
| Berndt A. E. Modig | M | 65 | 8 years | |
| Roger Jeffs | M | 62 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 1 years |
| Lawrence Olanoff | M | 72 | 2 years | |
| Peggy Phillips | F | 70 | 1 years | |
| Donald Jewell | M | - | 7 years | |
| Atul Pande | M | 69 | 8 years | |
| Bruce G. Cousins | M | 63 | 5 years | |
| George Bickerstaff | M | 68 | 2 years | |
| Andrew Lo | M | 63 | 6 years | |
| Wayne DeVeydt | M | 54 | 2 years | |
| Christian Oberbeck | M | - |
Harvard College
| 4 years |
| Kwame Owusu-Kesse | M | 40 |
Harvard College
| 4 years |
| Nicholas Downing | M | 39 |
Harvard College
| 4 years |
| Daniel West | M | 37 |
Harvard College
| 4 years |
| Brian Ru | M | - |
Harvard College
| 4 years |
| Andrew Griffin | M | - |
Harvard College
| 4 years |
| Chioma Achebe | F | - |
Harvard College
| 4 years |
| Adam Virgadamo | M | - |
Harvard College
| 4 years |
| Kristina Chang | F | - |
Harvard College
| 4 years |
| Ingrid Hammond | F | - |
Harvard College
| 5 years |
| Tracy Li | F | - |
Harvard College
| 4 years |
| David Chan | M | - |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | - |
| Raudel Yanez | M | - |
Harvard College
| 4 years |
| William I. Fradin | M | 42 |
Harvard College
| 4 years |
| Charlie Boutwell | M | - |
Harvard College
| 4 years |
| Dominic Hood | M | - |
Harvard College
| 4 years |
| James Thomas Berylson | M | 43 |
Harvard College
| 4 years |
| Ed Couch | M | 40 |
Harvard College
| 4 years |
| Michael Gladstone | M | 37 |
Harvard College
| 4 years |
| Aalap Mahadevia | M | - |
Harvard College
| 4 years |
| Luke Messac | M | - |
Harvard College
| 4 years |
| David Ganitsky | M | - |
Harvard College
| 4 years |
| Sam W. Spirn | M | - |
Harvard College
| 4 years |
| Grace Jiang | F | - |
Harvard College
| 4 years |
| Cyrus David Heidary | M | - |
Harvard College
| 4 years |
| Brian Christopher Holmquest | M | - |
Harvard College
| 4 years |
| Dong Han | F | - |
QVT Financial LP
QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | 2 years |
| Matthew Kozlov | M | - |
Harvard College
| 4 years |
| Meredith Max Hodges | F | 43 |
Harvard College
| 4 years |
| Brooks Powlen | M | - |
Harvard College
| 4 years |
| John-Paul Munfa | M | 42 |
Harvard College
| 4 years |
| Simon Kotzeff | M | - |
Harvard College
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 82 | 82.00% |
| United Kingdom | 27 | 27.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Vivek Ramaswamy
- Personal Network
